Journal of Vascular Surgery
Volume 48, Issue 6, Supplement , Pages 11S-16S , December 2008

Which is the best revascularization for critical limb ischemia: Endovascular or open surgery?

Presented as the Inaugural Robert B. Rutherford Lecture at the Second Annual Meeting of World Federation of Vascular Societies, San Diego, Jun 4, 2008.

  • Jonathan D. Beard, ChM, MEd, FRCS

      Affiliations

    • Corresponding Author InformationReprint requests: Jonathan D. Beard, Sheffield Vascular Institute, Northern General Hospital, Sheffield S5 7AU, UK

Received 6 August 2008 ,Accepted 12 August 2008.

References 

  1. Singh S, Evans L, Datta D, Gaines P, Beard JD. The costs of managing lower limb-threatening ischaemia. Eur J Vasc Endovasc Surg. 1996;12:359–362
  2. Johnson BF, Singh S, Evans L, Drury R, Datta D, Beard JD. A prospective study of the effect of limb-threatening ischaemia and its surgical treatment on the quality of life. Eur J Vasc Endovasc Surg. 1997;13:306–314
  3. Bradbury A, Wilmink T, Lee AJ, Bell J, Prescott R, Gillespie I, et al. Bypass versus angioplasty to treat severe limb ischemia: factors that effect treatment preferences of UK surgeons and interventional radiologists. J Vasc Surg. 2004;39:1026–1032
  4. Society of Interventional Radiology Standards of Practice Committee. Guidelines for percutaneous transluminal angioplasty. J Vasc Interv Radiol. 2003;14:S209–S217
  5. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG TASC II Working Group. Inter-Society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45(suppl):S5–S67
  6. Stoeckelhuber BM, Meissner O, Stoeckelhuber M, Wiesmann M, Kueffer G. Primary endovascular stent placements of focal infrarenal aortic stenosis (Initial and mid term results). J Vasc Interv Radiol. 2003;14:1443–1447
  7. Simons PC, Nawijn AA, Bruijninckx CM, Knippenberg B, de Vries EH, van Overhagen H. Long-term results of primary stent placement to treat infrarenal aortic stenosis. Eur J Vasc Endovasc Surg. 2006;32:627–633
  8. Coggia M, Javerliat I, Di Centa I, Colacchio G, Leschi JP, Kitzis M, et al. Total laparoscopic bypass for aortoiliac occlusive lesions: 93-case experience. J Vasc Surg. 2004;40:899–906
  9. Štádler P, Šebesta P, Vitásek P, Matouš P, El Samman K. A modified technique of transperitoneal direct approach for totally laparoscopic aortoiliac surgery. Eur J Vasc Endovasc Surg. 2006;32:266–269
  10. Aburahma AF, Robinson PA, Cook CC, Hopkins ES. Selecting patients for combined femorofemoral bypass grafting and iliac balloon angioplasty and stenting for bilateral iliac disease. J Vasc Surg. 2001;33(2 suppl):S93–S99
  11. Hertzer NR, Bena JF, Karafa MT. A personal experience with direct reconstruction and extra-anatomic bypass for aortoiliofemoral occlusive disease. J Vasc Surg. 2007;45:527–535
  12. Wittens CH, van Houtte HJ, van Urk H. European Prospective Randomised Multi-centre Axillo-bifemoral Trial. Eur J Vasc Surg. 1992;6:115–123
  13. Kim YW, Lee JH, Kim HG, Huh S. Factors affecting the long-term patency of crossover femorofemoral bypass graft. Eur J Vasc Endovasc Surg. 2005;30:376–380
  14. Pursell R, Sideso E, Magee TR, Galland RB. Critical appraisal of femorofemoral crossover grafts. Br J Surg. 2005;92:565–569
  15. Mingoli A, Sapienza P, Feldhaus RJ, Di Marzo L, Burchi C, Cavallaro A. Femorofemoral bypass grafts: factors influencing long-term patency rate and outcome. Surgery. 2001;129:451–458
  16. Ricco JB, Probst H. Long-term results of a multicenter randomized study on direct versus crossover bypass for unilateral iliac artery occlusive disease. J Vasc Surg. 2008;47:45–53
  17. Wolf GL, Wilson SE, Cross AP, Deupree RH, Stason WB. Surgery or balloon angioplasty for peripheral vascular disease; a randomised clinical trial. J Vasc Interv Radiol. 1993;4:639–648
  18. Ballard JL, Bergan JJ, Singh P, Yonemoto H, Killeen JD. Aortoiliac stent deployment versus surgical reconstruction: analysis of outcome and cost. J Vasc Surg. 1998;28:94–101
  19. Ring EJ. Percutaneous recanalisation of common iliac occlusions; an unacceptable complication rate. AJR Am J Roentgenol. 1982;139:587–589
  20. Nicholson AA. Aorbiliac intervention. In:  Cowley MG editors. Vascular interventional radiology. Berlin: Springer; 2007;p. 29–39
  21. Tetteroo E, van der Graaf Y, Bosch JL, van Engelen AD, Hunink MG, Eikelboom BC, et al. Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac-artery occlusive disease (Dutch Iliac Stent Trial Study Group). Lancet. 1998;351:1153–115918
  22. Klein WM, van der Graaf Y, Seegers J, Spithoven JH, Buskens E, van Baal JG, et al. Dutch iliac stent trial: long-term results in patients randomized for primary or selective stent placement. Radiology. 2006;238:734–744
  23. Bosch JL, Hunink MG. Stent or PTA in iliac “occlusive” disease (Meta-analysis of the results of PTA and stent placement in aortoiliac occlusive disease). Radiology. 1997;204:87–96
  24. Bosch JL. Iliac arterial disease: cost effectiveness analysis of stent placement vs PTA. Radiology. 1998;208:641–681
  25. Shanser A, Hevelone N, Owens CD, Belkin M, Bandyk DF, Clowes AW, et al. Technical factors affecting autogenous vein graft failure: observations from a large multicentre trial. J Vasc Surg. 2007;46:1180–1190
  26. Faries PL, Arora S, Pomposelli FB, Pulling MC, Smakowski P, Rohan DI, et al. The use of arm vein in lower-extremity revascularization: results of 520 procedures performed in eight years. J Vasc Surg. 2000;31:50–59
  27. Griffiths GD, Nagy J, Black D, Stonebridge PA. Randomized clinical trial of distal anastomotic interposition vein cuff in infrainguinal polytetrafluoroethylene bypass grafting. Br J Surg. 2004;91:560–562
  28. Veith FJ, Gupta SK, Ascer E, White-Flores S, Samson RH, Scher LA. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg. 1986;3:104–114
  29. Hunink MG, Wong JB, Donaldson MC, Meyerovitz MF, Harrington DP. Patency results of percutaneous and surgical revascularization for femoropopliteal arterial disease. Med Decis Making. 1994;14:71–81
  30. Mamode N, Scott RN. Graft type for femoro-popliteal bypass surgery. Cochrane Database Syst Rev. 2000;CD001487
  31. Jensen LP, Lepäntalo M, Fossdal JE. Dacron or PTFE for above knee femoropopliteal bypass (A multicenter randomised study). Eur J Vasc Endovasc Surg. 2007;34:44–49
  32. Rabbi JF, Kiran RP, Gersten G, Dudrick SJ, Dardik A. Early results with infra-inguinal cutting balloon angioplasty limits distal dissection. Ann Vasc Surg. 2004;18:640–643
  33. Laird J, Jaff MR, Biamino G, McNamara T, Scheinert D, Zetterlund P, et al. Cryoplasty for the treatment of femoropopliteal arterial disease; results of a prospective multicenter registry. J Vasc Interv Radiol. 2005;16:1067–1073
  34. Karthik S, Tuite DJ, Nicholson AA, Patel JV, Shaw DR, McPherson SJ, et al. Cryoplasty for arterial restenosis. Eur J Vasc Endovasc Surg. 2007;33:40–43
  35. Sabeti S, Schillinger M, Amighi J, Sherif C, Mlekusch W, Ahmadi R, et al. Primary patency of femoro-popliteal arteries treated with Nitinol stainless steel self expanding stents: propensity score adjusted analysis. Radiology. 2004;232:516–521
  36. Vogel TR, Shindelman LE, Nackman JB, Graham AM. Efficacious use of Nitinol stents in the femoral and popliteal arteries. J Vasc Surg. 2003;38:1178–1184
  37. Jahnke T, Voshage G, Müller-Hülsbeck S, Grimm J, Heller M, Brossmann J. Endovascular placement of self expanding Nitinol coiled stents for the treatment of femoropopliteal obstructive disease. J Vasc Interv Radiol. 2002;13:257–266
  38. Ahmadi R, Schillinger M, Maca T, Minar E. Femoropopliteal arteries: immediate and long term results for Dacron covered stent grafts. Radiology. 2002;223:345–350
  39. Jahnke T, Andresen R, Müller-Hülsbeck S, Schäfer FK, Voshage G, Heller M, et al. Hemobahn stent graft for treatment of femoropopliteal arterial obstruction; mid term results of a prospective trial. J Vasc Interv Radiol. 2003;14:41–51
  40. Deutschmann HA, Schedlbauer P, Bérczi V, Portugaller H, Tauss J, Hausegger KA. Placement of Hemobahn stent grafts in femoropopliteal arteries: early experience and mid term result in eighteen patients. J Vasc Interv Radiol. 2001;12:943–950
  41. Duda SH, Bosier SM, Lammer J, Scheinert D, Zeller T, Tielbeek A, et al. Sirolimus eluting vs bare Nitinol stents for obstructive superficial femoral artery disease (The SIROCCO II trial). J Vasc Interv Radiol. 2005;16:331–338
  42. Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Oliva V, et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther. 2006;13:701–710
  43. Tepe G, Zeller T, Albrecht T, Heller S, Schwarzwälder U, Beregi JP, et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med. 2008;14:689–699
  44. Spinosa DJ, Leung DA, Matsumoto AH, Bissonette EA, Cage D, Harthun NL, et al. Percutaneous intentional extraluminal recanalization in patients with chronic critical limb ischemia. Radiology. 2004;232:499–507
  45. Lazaris AM, Salas C, Tsiamis AC, Vlachou PA, Bolia A, Fishwick G, et al. Factors affecting patency of subintimal infrainguinal angioplasty in patients with critical lower limb ischemia. Eur J Vasc Endovasc Surg. 2006;32:668–674
  46. Soder HK, Manninen HI, Jaakkola P, Matsi PJ, Rasanen HT, Kaukanen E, et al. Prospective trial of infrapopliteal artery balloon angioplasty for critical limb ischemia: angiographic and clinical results. J Vasc Interv Radiol. 2000;11:1021–1031
  47. Vraux H, Hammer F, Verhelst R, Goffette P, Vandeleene B. Subintimal angioplasty of tibial vessel occlusions in the treatment of critical ischaemia: mid-term results. Eur J Vasc Endovasc Surg. 2000;20:441–446
  48. Adam AJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, et al. BASIL trial participants (Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial). Lancet. 2005;366:1925–1934
  49. Kedora J, Hohmann S, Garrett W, Munschaur C, Theune B, Gable D. Randomised comparison of percutaneous Viabahn stent grafts vs prosthetic femoro-popliteal bypass in the treatment of superficial femoral arterial occlusive disease. J Vasc Surg. 2007;45:10–16

 STATEMENT OF CONFLICT OF INTEREST: J. D. Beard reports that he has no conflicts of interest with the sponsor of this supplement article or products discussed in this article.

PII: S0741-5214(08)01387-6

doi: 10.1016/j.jvs.2008.08.036

Journal of Vascular Surgery
Volume 48, Issue 6, Supplement , Pages 11S-16S , December 2008

Article Tools